PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
5.24%
Revenue growth below 50% of CRWV's 23.55%. Michael Burry would check for competitive disadvantage risks.
13.18%
Cost growth 50-75% of CRWV's 19.16%. Bruce Berkowitz would examine sustainable cost advantages.
1.70%
Gross profit growth below 50% of CRWV's 25.15%. Michael Burry would check for structural issues.
-3.36%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
3.26%
R&D change of 3.26% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
67.17%
G&A growth while CRWV reduces overhead. John Neff would investigate operational differences.
10.79%
Marketing expense growth less than half of CRWV's 248.84%. David Dodd would verify if efficiency advantage is sustainable.
-22.58%
Other expenses reduction while CRWV shows 19.33% growth. Joel Greenblatt would examine efficiency.
12.99%
Operating expenses growth 50-75% of CRWV's 17.97%. Bruce Berkowitz would examine efficiency.
13.09%
Total costs growth 50-75% of CRWV's 18.28%. Bruce Berkowitz would examine efficiency.
-2.00%
Interest expense reduction while CRWV shows 1.19% growth. Joel Greenblatt would examine advantage.
30.75%
D&A growth 1.1-1.25x CRWV's 26.15%. Bill Ackman would demand investment justification.
-0.45%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-5.77%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-5.20%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-9.92%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-211.11%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-5.72%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-10.41%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-2.54%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-6.44%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-11.10%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-6.38%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-6.38%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-0.08%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.16%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.